Tell us about your search experience on the TGA website - complete our short survey
Notice for tozinameran & famtozinameran (COMIRNATY BIVALENT BA.4/BA.5 COVID-19 VACCINE) (Pfizer Australia Pty Ltd)
Active ingredients
tozinameran & famtozinameran
Sponsor
Date of review outcome
Lapse date
Type
Provisional determination
Indication
Booster for active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2
Therapeutic area
Infectious diseases